CALA.US Calithera Biosciences Inc

Financial Services Biotechnology USA Stocks
0.0003 USD
Close of Nov 14, 2026
0.0001 0.0010
Market cap
USD 1.46K
P/E
-
P/B
0.07x
ROE
-92.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2022.

Is CALA.US undervalued?

Graham number

The Graham number of Calithera Biosciences Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Calithera Biosciences Inc fundamental analysis

No fundamental analysis for Calithera Biosciences Inc yet.

Calithera Biosciences Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Calithera Biosciences Inc

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

Full company profile